Published in J Immunol on November 15, 1992
CD4 T cells: fates, functions, and faults. Blood (2008) 7.03
Active conservation of noncoding sequences revealed by three-way species comparisons. Genome Res (2000) 6.18
Strategies and tools for whole-genome alignments. Genome Res (2003) 4.86
Interleukin 2 plays a central role in Th2 differentiation. Proc Natl Acad Sci U S A (2004) 2.98
Identification of cis-acting regulatory elements controlling interleukin-4 gene expression in T cells: roles for NF-Y and NF-ATc. Mol Cell Biol (1993) 2.30
Multiple closely-linked NFAT/octamer and HMG I(Y) binding sites are part of the interleukin-4 promoter. Nucleic Acids Res (1993) 1.80
The enhancer HS2 critically regulates GATA-3-mediated Il4 transcription in T(H)2 cells. Nat Immunol (2010) 1.72
Patterns and rates of intron divergence between humans and chimpanzees. Genome Biol (2007) 1.61
Transcription of the interleukin 4 gene is regulated by multiple promoter elements. J Exp Med (1993) 1.40
PU.1 and GATA: components of a mast cell-specific interleukin 4 intronic enhancer. Proc Natl Acad Sci U S A (1994) 1.24
In TH2 cells the Il4 gene has a series of accessibility states associated with distinctive probabilities of IL-4 production. Proc Natl Acad Sci U S A (2002) 1.22
Mast cell IL-4 expression is regulated by Ikaros and influences encephalitogenic Th1 responses in EAE. J Clin Invest (2006) 1.19
Molecular dissection of the mouse interleukin-4 promoter. Proc Natl Acad Sci U S A (1993) 1.04
Regulation of the Il4 gene is independently controlled by proximal and distal 3' enhancers in mast cells and basophils. Mol Cell Biol (2007) 0.95
NFAT but not NF-kappaB is critical for transcriptional induction of the prosurvival gene A1 after IgE receptor activation in mast cells. Blood (2008) 0.94
T helper 2 (Th2) cell differentiation, type 2 innate lymphoid cell (ILC2) development and regulation of interleukin-4 (IL-4) and IL-13 production. Cytokine (2015) 0.92
Nuclear factor of activated T cells is associated with a mast cell interleukin 4 transcription complex. Mol Cell Biol (1996) 0.91
Transcriptional regulation of Th2 cell differentiation. Immunol Cell Biol (2010) 0.86
Phylogenetic and functional analysis identifies Ets-1 as a novel regulator of the Th2 cytokine gene locus. J Immunol (2009) 0.85
Interleukin-10 haplotypes in Celiac Disease in the Spanish population. BMC Med Genet (2006) 0.79
Activation of cytokine genes during primary and anamnestic immune response to inactivated c. albicans. Immunology (1996) 0.77
Two different negative regulatory elements control the transcription of T-cell activation gene 3 in activated mast cells. Biochem J (1997) 0.76
Regulatory elements and transcriptional control of chicken vasa homologue (CVH) promoter in chicken primordial germ cells. J Anim Sci Biotechnol (2017) 0.75
Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation (1987) 7.14
L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochem J (1982) 5.67
The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy (2001) 5.65
Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction. N Engl J Med (1987) 4.08
A review of the MHC genetics of rheumatoid arthritis. Genes Immun (2004) 3.77
Human hepatic lipase. Cloned cDNA sequence, restriction fragment length polymorphisms, chromosomal localization, and evolutionary relationships with lipoprotein lipase and pancreatic lipase. J Biol Chem (1988) 3.74
The electrophoretically 'slow' and 'fast' forms of the alpha 2-macroglobulin molecule. Biochem J (1979) 3.58
Identification of a human T lymphocyte surface protein associated with the E-rosette receptor. J Exp Med (1981) 3.06
Mice lacking the homologue of the human 22q11.2 gene CRKL phenocopy neurocristopathies of DiGeorge syndrome. Nat Genet (2001) 2.85
Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care STDS (1999) 2.55
Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J Exp Med (2000) 2.54
B cell stimulatory factor-1/interleukin-4 mRNA is expressed by normal and transformed mast cells. Cell (1987) 2.44
Cystatin, a protein inhibitor of cysteine proteinases. Improved purification from egg white, characterization, and detection in chicken serum. Biochem J (1983) 2.42
Renal artery stenosis and peripheral vascular disease: implications for ACE inhibitor therapy. Lancet (1990) 2.29
The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP. Pregnancy Hypertens (2014) 2.29
Relationships between perception of engagement with health care provider and demographic characteristics, health status, and adherence to therapeutic regimen in persons with HIV/AIDS. AIDS Patient Care STDS (2000) 2.21
Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma. J Virol (1992) 2.14
Acute renal failure following cardiac surgery: incidence, outcomes and risk factors. Aust N Z J Med (1995) 1.97
Studies of the pathophysiology of idiopathic detrusor instability: the physiological properties of the detrusor smooth muscle and its pattern of innervation. J Urol (2000) 1.87
Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. Am J Hum Genet (2001) 1.82
Suggestive linkage of the parathyroid receptor type 1 to osteoporosis. J Bone Miner Res (1999) 1.69
Deletion mapping and expression in Escherichia coli of the large genomic segment of a birnavirus. Virology (1987) 1.68
Cloning, isolation, and characterization of mammalian legumain, an asparaginyl endopeptidase. J Biol Chem (1997) 1.63
Identification of the probable inhibitory reactive sites of the cysteine proteinase inhibitors human cystatin C and chicken cystatin. J Biol Chem (1987) 1.61
Prevention of postpartum haemorrhage with sublingual misoprostol or oxytocin: a double-blind randomised controlled trial. BJOG (2012) 1.59
Effects of PTPN22 C1858T polymorphism on susceptibility and clinical characteristics of British Caucasian rheumatoid arthritis patients. Rheumatology (Oxford) (2006) 1.52
Isolation and characterisation of the NBR2 gene which lies head to head with the human BRCA1 gene. Hum Mol Genet (1997) 1.50
Critical assessment of use of central venous oxygen saturation as a mirror of mixed venous oxygen in severely ill cardiac patients. Circulation (1969) 1.47
Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators. Circulation (1997) 1.47
Purification of cathepsin B by a new form of affinity chromatography. Biochem J (1986) 1.45
Validation of the Sign and Symptom Check-List for Persons with HIV Disease (SSC-HIV). J Adv Nurs (1999) 1.43
A new human T-cell differentiation antigen: unexpected expression on chronic lymphocytic leukemia cells. Immunogenetics (1980) 1.43
Structure-function analysis of the Abm12 beta mutation using site-directed mutagenesis and DNA-mediated gene transfer. J Immunol (1987) 1.43
Prevalence and risk factors of maladaptive behaviour in young children with Autistic Disorder. J Intellect Disabil Res (2008) 1.35
Engaging recreational fishers in management and conservation: global case studies. Conserv Biol (2008) 1.33
Cardiac and skeletal muscle mitochondria have a monocarboxylate transporter MCT1. J Appl Physiol (1985) (1999) 1.32
Predominant association of HLA-B*2704 with ankylosing spondylitis in Chinese Han patients. Tissue Antigens (2009) 1.29
Substance P selectively activates TNF-alpha gene expression in murine mast cells. J Immunol (1993) 1.29
Genome-wide association study to identify genetic determinants of severe asthma. Thorax (2012) 1.27
Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants. J Med Genet (2005) 1.25
PU.1 and GATA: components of a mast cell-specific interleukin 4 intronic enhancer. Proc Natl Acad Sci U S A (1994) 1.24
Structural organization of the genes for murine and human leukemia inhibitory factor. Evolutionary conservation of coding and non-coding regions. J Biol Chem (1990) 1.22
Molecular characterization and cancer risk associated with BRCA1 and BRCA2 splice site variants identified in multiple-case breast cancer families. Hum Mutat (2005) 1.21
Human thimet oligopeptidase. Biochem J (1993) 1.20
Chicken liver Pz-peptidase, a thiol-dependent metallo-endopeptidase. Biochem J (1990) 1.18
Prospective meta-analysis of interleukin 1 gene complex polymorphisms confirms associations with ankylosing spondylitis. Ann Rheum Dis (2007) 1.18
Thimet oligopeptidase and oligopeptidase M or neurolysin. Methods Enzymol (1995) 1.17
CT features of plexiform neurofibroma of the submandibular gland. AJNR Am J Neuroradiol (2006) 1.16
An intron transcriptional enhancer element regulates IL-4 gene locus accessibility in mast cells. J Immunol (2000) 1.16
Generalized transduction in the enterobacterial phytopathogen Erwinia chrysanthemi. J Bacteriol (1980) 1.15
Association of IL23R and ERAP1 genes with ankylosing spondylitis in a Portuguese population. Clin Exp Rheumatol (2009) 1.15
Application of neurosonography to experimental physiology. J Neurosci Methods (2001) 1.13
Mechanisms of cortisol-induced hypertension in humans. Steroids (1995) 1.12
Non-inherited maternal HLA alleles are associated with rheumatoid arthritis. Rheumatology (Oxford) (2003) 1.11
Clearance of 141C3-labeled microspheres from blood and distribution in specific organs following intravenous and intraarterial administration in beagle dogs. J Pharm Sci (1980) 1.11
Is disease severity in ankylosing spondylitis genetically determined? Arthritis Rheum (2001) 1.10
Replication of association of IL1 gene complex members with ankylosing spondylitis in Taiwanese Chinese. Ann Rheum Dis (2005) 1.10
Does gestational hypertension become pre-eclampsia? Br J Obstet Gynaecol (1998) 1.10
Alterations of the p53 gene in nasopharyngeal carcinoma. J Virol (1992) 1.09
A continuous fluorimetric assay for clostridial collagenase and Pz-peptidase activity. Biochem J (1989) 1.09
Diet composition and insulin action in animal models. Br J Nutr (2000) 1.08
Distinct transcription start sites generate two forms of BRCA1 mRNA. Hum Mol Genet (1995) 1.08
Elucidating the chromosome 9 association with AS; CARD9 is a candidate gene. Genes Immun (2010) 1.08
Improved methods of assessing proteinuria in hypertensive pregnancy. Br J Obstet Gynaecol (1997) 1.08
Noninvasive estimation of regional myocardial oxygen consumption by positron emission tomography with carbon-11 acetate in patients with myocardial infarction. J Nucl Med (1989) 1.08
The influence of cimetidine versus ranitidine on doxepin pharmacokinetics. Eur J Clin Pharmacol (1987) 1.07
Structural analysis of the ileR locus of Escherichia coli K12. J Biol Chem (1986) 1.07
Cimetidine-doxepin interaction. J Clin Psychopharmacol (1985) 1.06
Non-B27 MHC associations of ankylosing spondylitis. Genes Immun (2006) 1.06
Vascular endothelial cells and granulopoiesis: interleukin-1 stimulates release of G-CSF and GM-CSF. Blood (1988) 1.06
Postsystolic shortening of acutely ischemic canine myocardium predicts early and late recovery of function after coronary artery reperfusion. Circulation (1988) 1.06
Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis. Ann Rheum Dis (2005) 1.05
Plasma uric acid remains a marker of poor outcome in hypertensive pregnancy: a retrospective cohort study. BJOG (2012) 1.04
Report of the Committee on School Health Program. Am J Public Health (N Y) (1922) 1.04
Regulation of BRCA1. Nature (1995) 1.04
Alternatively spliced RNAs encode several isoforms of CD46 (MCP), a regulator of complement activation. Immunogenetics (1991) 1.04
Mutations and alternative splicing of the BRCA1 gene in UK breast/ovarian cancer families. Genes Chromosomes Cancer (1997) 1.03
Two subphenotypes of childhood asthma that differ in maternal and paternal influences on asthma risk. Am J Respir Crit Care Med (1999) 1.03
'Sink or swim': an evaluation of the clinical characteristics of individuals with high bone mass. Osteoporos Int (2011) 1.03
Regulation of IL-4 production in mast cells: a paradigm for cell-type-specific gene expression. Immunol Rev (2001) 1.02
HASTE MR imaging: description of technique and preliminary results in the abdomen. J Magn Reson Imaging (1996) 1.02
Osteoblasts display receptors for and responses to leukemia-inhibitory factor. J Cell Physiol (1990) 1.02
Retinal pigment epithelial cells secrete interleukin-6 in response to interleukin-1. Invest Ophthalmol Vis Sci (1992) 1.02
Fine mapping of the MHC Class III region demonstrates association of AIF1 and rheumatoid arthritis. Rheumatology (Oxford) (2008) 1.02
Distress, coping, and social support among rural women recently diagnosed with primary breast cancer. Breast J (2001) 1.00
Mutations that convert the four leucine codons of the Salmonella typhimurium leu leader to four threonine codons. J Bacteriol (1985) 1.00
Fowl adenovirus recombinant expressing VP2 of infectious bursal disease virus induces protective immunity against bursal disease. Arch Virol (1998) 0.99
Effect of early treatment with propranolol on left ventricular function four weeks after myocardial infarction. Br Heart J (1985) 0.99
T-cell recognition of Ia molecules selectively altered by a single amino acid substitution. Science (1986) 0.99
Involvement of leukemia inhibitory factor and nerve growth factor in the development of dorsal root ganglion neurons. Development (1993) 0.99
Characterization of the molecular defect in a feline model for type II GM2-gangliosidosis (Sandhoff disease). Am J Pathol (1994) 0.99
Sensitivity of Altitudinal Ecotypes of the Wild Tomato Lycopersicon hirsutum to Chilling Injury. Plant Physiol (1989) 0.99
Leukemia inhibitory factor (LIF) infusion stimulates skeletal muscle regeneration after injury: injured muscle expresses lif mRNA. J Neurol Sci (1994) 0.97
The detailed characterisation of a 400 kb cosmid walk in the BRCA1 region: identification and localisation of 10 genes including a dual-specificity phosphatase. Hum Mol Genet (1994) 0.97
Predicting warfarin maintenance dosage based on initial response. Am J Hosp Pharm (1979) 0.97
Human plasma alpha-cysteine proteinase inhibitor. Purification by affinity chromatography, characterization and isolation of an active fragment. Biochem J (1984) 0.95
Brain natriuretic peptide is a potentially useful screening tool for the detection of cardiovascular disease in patients with rheumatoid arthritis. Ann Rheum Dis (2006) 0.95
Stroke in the Lehigh Valley: seasonal variation in incidence rates. Stroke (1987) 0.95
Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol. Lancet (1984) 0.94